000 01511 a2200397 4500
005 20250513133959.0
264 0 _c19980220
008 199802s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.42.1.140
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcDougall, B
245 0 0 _aDicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cJan 1998
300 _a140-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAcquired Immunodeficiency Syndrome
_xdrug therapy
650 0 4 _aCaffeic Acids
650 0 4 _aChlorogenic Acid
_xanalogs & derivatives
650 0 4 _aCinnamates
_xpharmacology
650 0 4 _aHIV Envelope Protein gp120
_xdrug effects
650 0 4 _aHIV Integrase
_xdrug effects
650 0 4 _aHIV Integrase Inhibitors
_xpharmacology
650 0 4 _aHIV Reverse Transcriptase
_xdrug effects
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aSuccinates
650 0 4 _aTartrates
_xpharmacology
700 1 _aKing, P J
700 1 _aWu, B W
700 1 _aHostomsky, Z
700 1 _aReinecke, M G
700 1 _aRobinson, W E
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 42
_gno. 1
_gp. 140-6
856 4 0 _uhttps://doi.org/10.1128/AAC.42.1.140
_zAvailable from publisher's website
999 _c9418395
_d9418395